Titlebook: Clinical Trials in Osteoporosis; Derek Pearson (Clinical Director),Colin G. Miller Book 20021st edition Springer-Verlag London 2002 Clini

儲備

organism

Satellite Tracking and ObservationModels, are discussed in other books and are not the remit of this book. However, because of the nature of this therapeutic area, it is important to consider the particular extras and details that have to be evaluated, and this chapter provides an overview of these items. The sponsor needs to be aware of t

藐視

Oliver Montenbruck,Eberhard Gille sponsor has made an assessment of the patient population and facilities available. It is now up to the investigator, site administrator and staff to prove the sponsor made the right decision in placing the study at their site. Since delays in study start-up can cause a sponsor to lose millions of

CAND

Conclusions and Future Actions,ol procedures, it also encompasses adequate subject preparation, technologist preparation, observance of rigorous scanning and analysis protocols, and the use of regular, organized data shipments to DXA quality assurance centers. All members of the research team should regard these aspects as necess

Pepsin

高度

逃避系列單詞

貧窮地活

Error and Uncertainty Characterizationed to that of the normal population. It would be free of side effects and sufficiently inexpensive for widespread use. Its beneficial effects on bone would persist for a significant time once therapy was withdrawn, opening the way to intermittent courses of treatment. It should be effective when giv

使無效

Graduated

Remote Sensing and Digital Image Processingsh BMD at a particular time. Using serial DXA measurements it is possible to measure a change in BMD over a set period of time. It is presumed that these measured changes in BMD are due to alterations in bone turnover, but they are not direct measurements of bone turnover. Furthermore, DXA scans and